This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San Diego

Palaniswami Rathanaswami, PhD
Senior Scientist, Biologics Discovery at Amgen, Inc.

Profile

Palaniswami Rathanaswami is working over 25 years in human therapeutic antibody generation with a special interest in antibody sequencing, engineering and screening. Developed technologies to measure the affinities in femtomolar range and measuring the affinity for on-cell membrane expressed targets. Author or inventor on more than 40 papers and patents.

Agenda Sessions

  • Strategies for High Affinity Screening in Therapeutic Antibody Discovery

    1:15pm